Articles
(Re)Thinking Psycho-oncology in a world out of balance: What I learned after a year of interviews
"One must imagine Sisyphus happy" Albert Camus Why me? This is probably the present-day question of every patient with cancer! One of the consequences of our chaotic reality is cancer, which belongs to that class of diseases that impacts the…
CancerWorld issue #103 (May, 2025)
What does it take to change the odds in cancer care? Innovation? Yes. But also: persistence. Collaboration. The refusal to accept that some lives matter less because of where they’re born. In this issue of CancerWorld, we focus not just…
Adrian Gottschalk: Making a Difference for His Fellow Human Beings
I grew up around a lot of physicians,” begins Adrian Gottschalk, President and CEO of Foghorn Therapeutics, a biotech company redefining how we understand and treat complex diseases by targeting the chromatin regulatory system. “My late father was a professor…
ACT for Children:A Global Initiative to Tackle Inequities in Pediatric Cancer
The disparity in childhood cancer outcomes is one of the world’s most pressing health inequities. While over 80% of children with cancer are cured in high-income countries (HICs), survival drops to less than 30% in low- and middle-income countries (LMICs).…
Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
Every year, the Sjöberg Prize, established by the Royal Swedish Academy of Sciences, honors researchers whose scientific discoveries in oncology are reshaping the understanding and treatment of cancer. The award stands alongside the most prestigious accolades in science, not only…
“I really care about people.” – Philip Kantoff, A Life in Science and Medicine
“I wanted to be a scientist when I grew up.” Boston. The city where old bricks and new ideas stand side by side. Where science, education, and innovation breathe together. The wind cuts through the streets of New England, sharp…
It’s no longer taboo to suggest that some metastatic breast cancers may be curable
It’s long been clear that, in most patients with metastatic HER-positive breast cancer, adding effective HER2 blockade to cytotoxics can result in very prolonged responses. Janet Fricker reports on the prospective trials building evidence on whether – and in whom…
Istanbul, Ankara take action on HPV vaccination, as government delays promised national programme
The two largest cities in Türkiye have stepped in to promote HPV vaccination at a local level, including free inoculation for young people from the poorest families, as the state fails to deliver on its commitment to add HPV to…
Could this dual approach be the frontier that finally gets immunotherapy to work for MSS colorectal cancer?
It is often said in medicine that the only true constant in facing life-threatening diseases is change. Nowhere is this more evident than in oncology, where advances in chemotherapy, targeted therapies, immunotherapies, and other novel agents continue to spark hope.…
Sleep & Cancer: Why Rest Matters More Than You Think?
Difficulty sleeping and disturbed sleep patterns are not uncommon among cancer patients, and alleviating these symptoms has always been integral to good cancer care. Now, mounting evidence of the impact that getting enough deep sleep can have on outcomes in…